Corvus Pharmaceuticals
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRVS and other ETFs, options, and stocks.About CRVS
Corvus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor.
CEORichard A. Miller
CEORichard A. Miller
Employees28
Employees28
HeadquartersBurlingame, California
HeadquartersBurlingame, California
Founded2014
Founded2014
Employees28
Employees28
CRVS Key Statistics
Market cap36.28M
Market cap36.28M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume218.55K
Average volume218.55K
High today$0.80
High today$0.80
Low today$0.695
Low today$0.695
Open price$0.7073
Open price$0.7073
Volume191.09K
Volume191.09K
52 Week high$7.11
52 Week high$7.11
52 Week low$0.695
52 Week low$0.695
CRVS Earnings
-$0.34
-$0.23
-$0.11
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated— per share
Estimated— per share
ActualExpected Oct 31, After Hours
ActualExpected Oct 31, After Hours